Bipolar disorder refers to a brain disorder that leads to infrequent episodes in activity levels, energy, mood, and the capacity to perform daily tasks. The case involves a 26-year-old woman of Korean descent who has been hospitalized for 21-days from onset of acute mania. She was diagnosed with Bipolar I disorder which is characterized by manic episodes that last for more than seven days coupled with acute manic symptoms that necessitate hospital care. Incidences of depression take place and a mixture of manic and depression symptoms are likely to occur. She weighs 110 lbs. and is 5’5”. Genetic testing reveals that she is positive for CYP2D6*10 allele. She admits that she stopped taking her lithium, which was prescribed, in the hospital she was discharged two weeks ago. Mental exam results indicated that the young mania rating scale (YMRS) score is 22.
Decision 1: Prescribe Lithium 300 mg orally BID
Rationale for this decision
The American Psychiatric Association has certified the utilization of lithium prescriptions in treatment of bipolar I disorder among young adults. I have decided to use Lithium 300 mg orally BID because it is a mood stabilize and can treat depression and acute mania (Stahl, 2013). For the 26-year-old Korean woman, her mood is quite high leading to excitable and overactive behaviour. The drug would also help the patient in managing low and high moods as well as stabilize behavioural disorders especially self-harming or aggressive behaviours. Similarly, I decided to use lithium because it minimizes the frequency and intensity of mood swings. The medicine has the capacity to influence the amount of some chemical substances available in the brain (Gerhard et al., 2015). It influences the manner in which the nerve cells react to particular chemical substances.
By prescribing this drug, I was anticipating that it would be effective in stabilizing manic episodes in the Korean woman. Precisely, I expected the drug would assist in minimizing the intensity and frequency of mood swings (Goodwin et al., 2017). Therefore, I expected the Young Mania Rating Scale (YMRS) score to be less than 22. The patient will improve on abnormal behavioural issues. For instance, I expected the patient to register improvement in necessity for sleep and reduce hyperactivity. The patient would also reduce instances of dressing oddly and improve the speech (Gerhard et al., 2015). Finally, I also expected that she would minimize her behaviour of denying